Profile
Read Simon (also appears as Simon Read) is associated with Dianthus Therapeutics, Inc. according to SEC filings dated May 22, 2026. The filings do not publicly disclose a specific title, tenure, or biography, and public sources do not provide a detailed professional history for this individual. Given the limited public information, the person is not identified as a widely notable figure. If this name represents a different individual in other contexts, please provide additional identifiers.
| Role | Insider |
|---|
| Notability | 20/100 |
|---|
Board memberships
- Dianthus Therapeutics, Inc.
Frequently Asked Questions
Who is Read Simon?
Read Simon (also appears as Simon Read) is associated with Dianthus Therapeutics, Inc. according to SEC filings dated May 22, 2026. The filings do not publicly disclose a specific title, tenure, or biography, and public sources do not provide a detailed professional history for this individual. Given the limited public information, the person is not identified as a widely notab…
How many SEC Form 4 filings has Read Simon submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Read Simon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.